Potency Assays and Release Testing of CAR T-Cell Therapies
CAR T-cell therapy represents a significant shift in the treatment landscape for cancer, particularly in hematologic malignancies. Unlike traditional immunotherapies, Chimeric Antigen Receptor (CAR) T-cells are genetically engineered T lymphocytes














